3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
25
Lymphoma
15
Neutropenia
9
Lymphoma, Large B-Cell, Diffuse
7
Leukemia
7
Carcinoma, Non-Small-Cell Lung
7
Neoplasms
6
Lymphoma, Follicular
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Triple Negative Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Ovarian Neoplasms
4
Hodgkin Disease
4
Chemotherapy-induced Neutropenia
4
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell, Marginal Zone
3
Colorectal Neoplasms
3
Burkitt Lymphoma
3
Breast Neoplasms, Male
3
Adenocarcinoma, Bronchiolo-Alveolar
3
Adenocarcinoma of Lung
3
Waldenstrom Macroglobulinemia
2
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Interventions
fludarabine phosphate
19
Peripheral Blood Stem Cell Transplantation
15
Cyclophosphamide
15
Whole-Body Irradiation
14
Tacrolimus
13
Mycophenolic Acid
13
Busulfan
12
Antilymphocyte Serum
11
Rituximab
9
Etoposide
7
Methotrexate
6
Cyclosporine
6
Melphalan
5
thymoglobulin
4
Flow Cytometry
4
Carboplatin
4
Therapeutics
3
Radiotherapy
3
Lenalidomide
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Everolimus
3
Amplified Fragment Length Polymorphism Analysis
3
Alemtuzumab
3
fludarabine
2
Vorinostat
2
Vincristine
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Extranodal NK-T-Cell
×
pegfilgrastim
×
Clear all
No trials found.